-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mirdametinib in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mirdametinib in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mirdametinib in Metastatic Breast Cancer Drug Details: mirdametinib (PD-0325901) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selumetinib Sulfate in Low-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selumetinib Sulfate in Low-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selumetinib Sulfate in Low-Grade Glioma Drug Details: Selumetinib sulfate (Koselugo /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selumetinib Sulfate in Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selumetinib Sulfate in Glioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selumetinib Sulfate in Glioma Drug Details: Selumetinib sulfate (Koselugo / Cocellugo...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selumetinib Sulfate in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selumetinib Sulfate in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selumetinib Sulfate in Peripheral Nerve Sheath Tumor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DB-1303 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DB-1303 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DB-1303 in Esophageal Cancer Drug Details: DB-1303 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gamma-PN in Streptococcal Pneumonia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gamma-PN in Streptococcal Pneumonia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Gamma-PN in Streptococcal Pneumonia Drug Details: Gamma-PN vaccine is under development for the...
-
Sector Analysis
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Neuromodulation Devices Market Report Overview The neuromodulation devices market size was valued at $6.06 billion in 2023. Factors such as deep brain stimulation and spinal cord stimulation will drive the market growth at a CAGR of more than 6% from 2023 to 2033. Neuromodulation is one of the fastest-growing medical device markets. Within the last 10 years, the market has grown exponentially, with spinal cord stimulation being the largest market. Neuromodulation Devices Market Outlook 2023-2033 ($ Billion) Buy Full Report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mirdametinib in Melanoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Mirdametinib in Melanoma Drug Details: mirdametinib (PD-0325901) is under development for the treatment of neurofibromatosis...
-
Product Insights
Emlichheim Biomass Power Plant
Emlichheim Biomass Power Plant is a biopower project located in Lower Saxony, Germany. The project was developed by PN Biomasseheizkraftwerk Emlichheim GmbH & Co. KG. The project came online in 2006. Empower your strategies with our Emlichheim Biomass Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Essel Infraprojects Lakhmir Wala Solar PV Park
Essel Infraprojects Lakhmir Wala Solar PV Park is a solar PV project located in Punjab, India. The project is owned by Adani Green Energy Ltd; Total Solar Singapore Pte Ltd and was developed by Essel Infraprojects Ltd; PN Clean Energy Ltd. The project came online in 2015. Empower your strategies with our Essel Infraprojects Lakhmir Wala Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report...